Daiwa Securities Group’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29K | Buy |
225
+15
| +7% | +$1.93K | ﹤0.01% | 1088 |
|
|
2025
Q1 | $19K | Hold |
210
| – | – | ﹤0.01% | 1071 |
|
|
2024
Q4 | $18K | Sell |
210
-27
| -11% | -$2.31K | ﹤0.01% | 1087 |
|
|
2024
Q3 | $22K | Hold |
237
| – | – | ﹤0.01% | 1095 |
|
|
2024
Q2 | $26K | Sell |
237
-4
| -2% | -$439 | ﹤0.01% | 1116 |
|
|
2024
Q1 | $23K | Hold |
241
| – | – | ﹤0.01% | 1125 |
|
|
2023
Q4 | $22K | Hold |
241
| – | – | ﹤0.01% | 1109 |
|
|
2023
Q3 | $12K | Hold |
241
| – | – | ﹤0.01% | 1112 |
|
|
2023
Q2 | $15K | Hold |
241
| – | – | ﹤0.01% | 1113 |
|
|
2023
Q1 | $11K | Hold |
241
| – | – | ﹤0.01% | 1096 |
|
|
2022
Q4 | $11K | Buy |
241
+19
| +9% | +$867 | ﹤0.01% | 1102 |
|
|
2022
Q3 | $15K | Hold |
222
| – | – | ﹤0.01% | 1100 |
|
|
2022
Q2 | $11K | Buy |
222
+50
| +29% | +$2.48K | ﹤0.01% | 1127 |
|
|
2022
Q1 | $11K | Hold |
172
| – | – | ﹤0.01% | 1127 |
|
|
2021
Q4 | $18K | Sell |
172
-29
| -14% | -$3.04K | ﹤0.01% | 1114 |
|
|
2021
Q3 | $21K | Buy |
201
+86
| +75% | +$8.99K | ﹤0.01% | 1096 |
|
|
2021
Q2 | $10K | Hold |
115
| – | – | ﹤0.01% | 1041 |
|
|
2021
Q1 | $11K | Buy |
115
+10
| +10% | +$957 | ﹤0.01% | 1040 |
|
|
2020
Q4 | $12K | Sell |
105
-204
| -66% | -$23.3K | ﹤0.01% | 1004 |
|
|
2020
Q3 | $29K | Buy |
309
+8
| +3% | +$751 | ﹤0.01% | 960 |
|
|
2020
Q2 | $18K | Hold |
301
| – | – | ﹤0.01% | 1014 |
|
|
2020
Q1 | $18K | Buy |
301
+23
| +8% | +$1.38K | ﹤0.01% | 1003 |
|
|
2019
Q4 | $22K | Sell |
278
-35
| -11% | -$2.77K | ﹤0.01% | 995 |
|
|
2019
Q3 | $23K | Buy |
313
+6
| +2% | +$441 | ﹤0.01% | 979 |
|
|
2019
Q2 | $29K | Buy |
307
+27
| +10% | +$2.55K | ﹤0.01% | 981 |
|
|
2019
Q1 | $22K | Buy |
280
+40
| +17% | +$3.14K | ﹤0.01% | 979 |
|
|
2018
Q4 | $13K | Hold |
240
| – | – | ﹤0.01% | 977 |
|
|
2018
Q3 | $19K | Hold |
240
| – | – | ﹤0.01% | 992 |
|
|
2018
Q2 | $15K | Hold |
240
| – | – | ﹤0.01% | 1011 |
|
|
2018
Q1 | $22K | Buy |
+240
| New | +$22K | ﹤0.01% | 978 |
|